Literature DB >> 2554882

Desensitization of calcium mobilization and cell function in human neutrophils.

G H Lee1, J S Kaptein, S J Scott, H Niedzin, C I Kalunta, P M Lad.   

Abstract

Neutrophils pretreated with the chemoattractant formylmethionyl-leucyl-phenylalanine become unresponsive when re-exposed to the same ligand, a process termed desensitization. We have examined whether desensitization of transduction (Ca2+ mobilization) or of other cell functions (superoxide generation, enzyme release, or aggregation) occurs synchronously. Simultaneous studies of Ca2+ mobilization and aggregation by using Fura-2-loaded cells indicate that, under conditions where the aggregation response is abolished, most of the Ca2+ mobilization is unaltered. Further studies were then carried out to ascertain whether desensitization of Ca2+ mobilization could in fact be induced. Desensitization was observed, and was dependent on the number of exposures of the cells to the ligand, the concentration of the ligand, and whether the ligand was left in the medium or was removed. The pattern of resensitization was dependent on the experimental design. Under conditions where ligand was continuously present, no recovery of the Ca2+-mobilization response was seen with subsequent challenges. In contrast, on removal of ligand, this response showed partial recovery. Whereas complete desensitization of aggregation was noted, enzyme release showed a markedly lesser degree of desensitization and required more frequent exposures to the ligand before it was observed. Little or no desensitization of superoxide generation was observed regardless of the conditions utilized. Studies using phorbol myristate acetate as the ligand showed that Ca2+ mobilization and aggregation could be simultaneously inhibited. Our results suggest that discrete mechanisms of desensitization are possible in human neutrophils, and that desensitization of one particular function (aggregation) does not imply concomitant desensitization of other functions.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2554882      PMCID: PMC1133243          DOI: 10.1042/bj2620165

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  25 in total

Review 1.  Ligand-receptor dynamics and signal amplification in the neutrophil.

Authors:  L A Sklar
Journal:  Adv Immunol       Date:  1986       Impact factor: 3.543

Review 2.  The O2- -forming NADPH oxidase of the phagocytes: nature, mechanisms of activation and function.

Authors:  F Rossi
Journal:  Biochim Biophys Acta       Date:  1986-11-04

3.  Protein kinase C phosphorylates the inhibitory guanine-nucleotide-binding regulatory component and apparently suppresses its function in hormonal inhibition of adenylate cyclase.

Authors:  T Katada; A G Gilman; Y Watanabe; S Bauer; K H Jakobs
Journal:  Eur J Biochem       Date:  1985-09-02

4.  A new generation of Ca2+ indicators with greatly improved fluorescence properties.

Authors:  G Grynkiewicz; M Poenie; R Y Tsien
Journal:  J Biol Chem       Date:  1985-03-25       Impact factor: 5.157

5.  Specific interaction between phosphatidylinositol 4,5-bisphosphate and profilactin.

Authors:  I Lassing; U Lindberg
Journal:  Nature       Date:  1985 Apr 4-10       Impact factor: 49.962

6.  Protein kinase C phosphorylates human platelet inositol trisphosphate 5'-phosphomonoesterase, increasing the phosphatase activity.

Authors:  T M Connolly; W J Lawing; P W Majerus
Journal:  Cell       Date:  1986-09-12       Impact factor: 41.582

7.  Light scattering by polymorphonuclear leukocytes stimulated to aggregate under various pharmacologic conditions.

Authors:  I Yuli; R Snyderman
Journal:  Blood       Date:  1984-09       Impact factor: 22.113

8.  Selective desensitization of neutrophils: further studies with 1-O-alkyl-sn-glycero-3-phosphocholine analogues.

Authors:  J T O'Flaherty; C J Lees; C H Miller; C E McCall; J C Lewis; S H Love; R L Wykle
Journal:  J Immunol       Date:  1981-08       Impact factor: 5.422

9.  Regulation of the association of membrane skeletal protein 4.1 with glycophorin by a polyphosphoinositide.

Authors:  R A Anderson; V T Marchesi
Journal:  Nature       Date:  1985 Nov 21-27       Impact factor: 49.962

10.  Consequences of chemotactic peptide receptor modulation for leukocyte orientation.

Authors:  S H Zigmond
Journal:  J Cell Biol       Date:  1981-03       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.